89 related articles for article (PubMed ID: 22768592)
21. Metformin: intrinsic vasculoprotective properties.
Wiernsperger NF
Diabetes Technol Ther; 2000; 2(2):259-72. PubMed ID: 11469268
[No Abstract] [Full Text] [Related]
22. Cancer research. Cancer prevention with a diabetes pill?
Taubes G
Science; 2012 Jan; 335(6064):29. PubMed ID: 22223788
[No Abstract] [Full Text] [Related]
23. [Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
Neye H
Pharm Unserer Zeit; 2002; 31(3):264-70. PubMed ID: 12071123
[No Abstract] [Full Text] [Related]
24. [Treatment of type 2 diabetes with metformin].
Amouyal C; Andreelli F
Rev Prat; 2015 Dec; 65(10):1245-9. PubMed ID: 26979012
[No Abstract] [Full Text] [Related]
25. [40 years of Metformin in the treatment of diabetes mellitus].
Internist (Berl); 1997 Jul; 38(7 Suppl 40 Jahre):1-8. PubMed ID: 9330653
[No Abstract] [Full Text] [Related]
26. Metformin and insulin meet in a most atypical way.
White MF
Cell Metab; 2009 Jun; 9(6):485-7. PubMed ID: 19490902
[TBL] [Abstract][Full Text] [Related]
27. Metformin in heart failure.
Inzucchi SE; Masoudi FA; McGuire DK
Diabetes Care; 2007 Dec; 30(12):e129. PubMed ID: 18042738
[No Abstract] [Full Text] [Related]
28. Diabetes in the new General Medical Services contract: targets and adherence to metformin therapy.
Kirby M
Int J Clin Pract; 2005 Mar; 59(3):263-6. PubMed ID: 15857318
[No Abstract] [Full Text] [Related]
29. The target of metformin in type 2 diabetes.
Ferrannini E
N Engl J Med; 2014 Oct; 371(16):1547-8. PubMed ID: 25317875
[No Abstract] [Full Text] [Related]
30. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
Bosi E
Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
[TBL] [Abstract][Full Text] [Related]
31. Pioglitazone/metformin (Actoplus met).
Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
[No Abstract] [Full Text] [Related]
32. Sitagliptin/metformin (Janumet) for type 2 diabetes.
Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377
[No Abstract] [Full Text] [Related]
33. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
Almirall J; Bricullé M; Gonzalez-Clemente JM
Nephrol Dial Transplant; 2008 Jul; 23(7):2436-8. PubMed ID: 18388117
[No Abstract] [Full Text] [Related]
34. [Insulin sparing and metabolic control with metformin-insulin combination].
Isnard F
Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986
[No Abstract] [Full Text] [Related]
35. Choosing first-line therapy for management of type 2 diabetes.
Graber MA; Darby-Stewart A; Dachs R
Am Fam Physician; 2008 Jan; 77(1):16-7. PubMed ID: 18236820
[No Abstract] [Full Text] [Related]
36. Diabetes control without weight gain.
Health News; 1999 Apr; 5(5):6. PubMed ID: 10214130
[No Abstract] [Full Text] [Related]
37. Treatment with metformin is protective against limitations in instrumental activities of daily living in older subjects with type 2 diabetes mellitus.
Mazziotti G; Bossoni S; Orini S; Salimbeni P; Gazzaruso C; Solerte BS; Vescovi P; Romanelli G; Giustina A
J Am Geriatr Soc; 2009 Mar; 57(3):562-4. PubMed ID: 19278401
[No Abstract] [Full Text] [Related]
38. [Metformin in the UKPDS study. Metabolic and vascular results].
Basin C; Isnard F
Journ Annu Diabetol Hotel Dieu; 1999; ():243-61. PubMed ID: 10732421
[No Abstract] [Full Text] [Related]
39. Metformin in type 2 diabetes.
Fox GN
J Fam Pract; 2004 Nov; 53(11):900. PubMed ID: 15527727
[No Abstract] [Full Text] [Related]
40. Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.
Scherbaum WA
Diabetes Obes Metab; 2009 May; 11 Suppl 2():1-2. PubMed ID: 19385977
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
